Oncologic Emergencies: TLS Flashcards
TLS definition
Large number of cancer cells dies within a short period and cell contents are released into the blood
Electrolyte disturbances in TLS
Hyperkalemia
Hyperphosphatemia
Hypocalcemia
Hyperuricemia
Lab TLS
≥2 electrolyte abnormalities within 3 days before or 7 days after treatment initiation
Hyperkalemia definition
≥6.0 mEq/L
ECG abnormalities, cardiac arrest, fatigue
Hyperuricemia definition
≥8.0 mEq/L
AKI, crystal neuropathy
Hyperphosphatemia definition
≥4.5 mEq/L
AKI, GI upset, AMS
Hypocalcemia definition
≤7.0 mg/dl
AMS, seizures, arrhythmias, tetany, spasms
Clinical TLS definition
Presence of lab TLS plus AKI, seizures or neuromuscular irritability, cardiac arrhythmia
Cancer-related TLS risk factors
high proliferation rate, tumor bulk, circulating tumor cells, sensitivity to cytotoxic therapy
Patient-specific TLS risk factors
elevated baseline uric acid, nephropathy, hydration status, hypotension, acidic urine, LV dysfunction/HF
TLS prevention
Hold causative agents: diuretics, calcium/potassium/phosphate-containing supplements and nutritional products, ACEis, nephrotoxic agents
Hydration: IV NS, avoid adding bicarb
Risk-based prevention: based on low, intermediate, high risk
Low risk for TLS
Observation, normal hydration, monitoring
Intermediate risk for TLS
Hydration, allopurinol, consider rasburicase
High risk for TLS
Hydration, rasburicase, allopurinol
(Dialysis if refractory to rasburicase)
Indications for dialysis
refractory volume overload, oliguria, or anuria; persistent hyperkalemia or hyperuricemia, hyperphosphatemia-induced symptomatic hypocalcemia
Hyperkalemia treatment
Hydration, use diuretics to optimize urine output
Calcium chloride 1g IV
Regular insulin 10 units PLUS IV dextrose 25g
Sodium bicarb 50 mEq IV
SPS 15-60g PO
Hemodialysis or CRRT
Hyperphosphatemia treatment
First-line is IV hydration
Restrict dietary intake to 800-1000mg/day
Phosphate binders
Last-line: dialysis
Phosphate binders
Calcium acetate
Calcium carbonate
Aluminum hydroxide
Lanthanum
Sevelamer
Hypocalcemia treatment
Typically resolves with Hyperphosphatemia treatment, only treat symptomatic hypocalcemia to avoid overcorrection (cardiac arrhythmias, seizures, tetany)
Indication for allopurinol in TLS
Patients at risk for developing TLS
Initiate 24hrs prior to chemo
Allopurinol cautions
Drug interactions, severe hypersensitivity
Rasburicase indication in TLS
Suitable for patients with preexisting hyperuricemia before treatment, those at high risk for TLS, or patients with spontaneous TLS
Rasburicase cautions
G6PD deficiency
Cost (super expensive)